Multiple myeloma: open trials in Chile

5 open trials have a site in Chile. Registry data; only the trial team decides who can take part.

NCT07222761
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Clínica UC San Carlos de Apoquindo, Santiago · Clinica Alemana de Santiago, Santiago · Hospital Clinico Universidad de Los Andes, Santiago · OncoPrecision, Santiago · Centro de Investigaciones Clinicas Vina Del Mar, Viña del Mar
Registry updated 2026-11-04
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Celgene
Santiago · Santiago · Viña del Mar
Registry updated 2026-10-30
NCT05669989
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Trial Treatment · Phase 2 · Sanofi
Temuco
Registry updated 2026-10-15
NCT05730036
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Clinica Alemana de Santiago, Santiago · Fundacion Arturo Lopez Perez, Santiago · Centro Oncologia de Precision Universidad Mayor, Santiago · Hospital Clinico Universidad de Los Andes, Santiago · Clínica UC San Carlos de Apoquindo, Santiago · Centro de Investigaciones Clinicas Vina Del Mar, Viña del Mar
Registry updated 2026-10-07
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Trial Treatment · Phase 3 · Pfizer
FALP, Providencia · Clínica Inmunocel, Santiago · Clínica Universidad de Los Andes, Santiago · Clinica Alemana de Santiago, Santiago · FALP, Santiago
Registry updated 2026-08-24

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Multiple myeloma: open trials in Chile

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)